Evgenii V. Bryancev
Evgenii V. Bryancev has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Elena N. Plakhotina
Vidnoye Perinatal Center
4 shared publications - Tamara N. Belousova
Vidnoye Perinatal Center
4 shared publications - A. N. Kuzovlev
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Ministry of Education and Science of Russia
2 shared publications - N. B. Kuzina
Vidnovsky Perinatal Center
2 shared publications - Alina A. Akhmetshina
Avtsyn Research Institute of Human Morphology of FSBSI Petrovsky National Research Center of Surgery, Moscow, Russia
1 shared publication - D. V. Kassina
M.F. Vladimirsky Moscow Regional Research Clinical Institute
1 shared publication
Latest Publications
- Open Access
- 6 September 2025
- Published by The Scientific and Practical Society of Emergency Medicine Physicians in Russian Sklifosovsky Journal "Emergency Medical Care"
- Vol. 14 (2) , 277-293
Potential of Therapeutic Apheresis for Prolongation of Pregnancy in Early-Onset Preeclampsia
Preeclampsia with onset between 20 and 34 weeks is conditioned by the development of endothelial dysfunction caused by increased secretion of antiangiogenic factors, activation of the immune system, and the synthesis of inflammatory mediators. This complication is responsible for the progression of multiple organ failure in the mother, and more than 60,000 maternal deaths annually worldwide. The only method of therapy at present is early delivery. Such tactics lead to high neonatal morbidity and mortality.AIM OF STUDY To evaluate the possibilities of safely prolonging pregnancy using therapeutic apheresis methods in the development of early-onset preeclampsia.MATERIAL AND METHODS A prospective randomized study was conducted involving 58 patients diagnosed with early-onset severe preeclampsia. The patients were divided into three groups. The patients of the first group underwent 2 sessions of cascade plasma filtration with a total processed plasma volume of 4810 (3250; 5680) ml. In the second group, hemoperfusion was performed with a perfusion volume of 18,460 (16.890; 21.350) ml in two sessions. At the stages of the study, the dynamics of clinical and laboratory parameters of the mother and newborn were assessed in comparison with the control group.The use of cascade plasma filtration statistically significantly reduced the sFlt-1/PIGF ratio (p=0.017), pregnancy was prolonged by 32.5 (5.5; 42.5) days, the gestational age at delivery was 34.1 (29.6; 36.0) weeks. When using hemoperfusion, the level of neutrophil extracellular traps decreased statistically significantly. Pregnancy was prolonged by 26.5 (8; 52) days, the patients gave birth at a gestational age of 34.3 (33.5; 36.8) weeks. In the control group, the duration of pregnancy prolongation was 5.5 (2;7) days, pCONCLUSION The use of therapeutic apheresis techniques in patients with early-onset preeclampsia may allow for safe prolongation of pregnancy in the interests of the fetus, which requires further study.
- 6 September 2025
- Published by The Scientific and Practical Society of Emergency Medicine Physicians in Russian Sklifosovsky Journal "Emergency Medical Care"
- Vol. 14 (2) , 277-293
Open AccessPotential of Therapeutic Apheresis for Prolongation of Pregnancy in Early-Onset Preeclampsia
Preeclampsia with onset between 20 and 34 weeks is conditioned by the development of endothelial dysfunction caused by increased secretion of antiangiogenic factors, activation of the immune system, and the synthesis of inflammatory mediators. This complication is responsible for the progression of multiple organ failure in the mother, and more than 60,000 maternal deaths annually worldwide. The only method of therapy at present is early delivery. Such tactics lead to high neonatal morbidity and mortality.AIM OF STUDY To evaluate the possibilities of safely prolonging pregnancy using therapeutic apheresis methods in the development of early-onset preeclampsia.MATERIAL AND METHODS A prospective randomized study was conducted involving 58 patients diagnosed with early-onset severe preeclampsia. The patients were divided into three groups. The patients of the first group underwent 2 sessions of cascade plasma filtration with a total processed plasma volume of 4810 (3250; 5680) ml. In the second group, hemoperfusion was performed with a perfusion volume of 18,460 (16.890; 21.350) ml in two sessions. At the stages of the study, the dynamics of clinical and laboratory parameters of the mother and newborn were assessed in comparison with the control group.The use of cascade plasma filtration statistically significantly reduced the sFlt-1/PIGF ratio (p=0.017), pregnancy was prolonged by 32.5 (5.5; 42.5) days, the gestational age at delivery was 34.1 (29.6; 36.0) weeks. When using hemoperfusion, the level of neutrophil extracellular traps decreased statistically significantly. Pregnancy was prolonged by 26.5 (8; 52) days, the patients gave birth at a gestational age of 34.3 (33.5; 36.8) weeks. In the control group, the duration of pregnancy prolongation was 5.5 (2;7) days, pCONCLUSION The use of therapeutic apheresis techniques in patients with early-onset preeclampsia may allow for safe prolongation of pregnancy in the interests of the fetus, which requires further study.
- Open Access
- 27 February 2025
- Published by Scientific Research Institute - Ochapovsky Regional Clinical Hospital No 1 in Innovative Medicine of Kuban
- Vol. 10 (1) , 144-150
Therapeutic Apheresis in Early-Onset Preeclampsia: Literature Review
Preeclampsia is a multisystem disorder that manifests after 20 weeks’ gestation. It is a leading cause of maternal and fetal morbidity and mortality. Approximately 25% of early-onset preeclampsia cases are severe, and 85% of pregnant women with severe preeclampsia develop multiple organ failure. Stillbirth and early neonatal mortality in women with early-onset preeclampsia are 3%-5% higher than those in cases of late-onset preeclampsia. Birth asphyxia is diagnosed in 100% of newborns. Invasive respiratory support is required in 80% of cases. Every fourth newborn has cardiovascular and central nervous system issues.The analyzed literature demonstrated a possibility of pregnancy prolongation in early-onset preeclampsia using different therapeutic apheresis techniques, which can reduce negative consequences for newborns and mothers.
- 27 February 2025
- Published by Scientific Research Institute - Ochapovsky Regional Clinical Hospital No 1 in Innovative Medicine of Kuban
- Vol. 10 (1) , 144-150
Open AccessTherapeutic Apheresis in Early-Onset Preeclampsia: Literature Review
Preeclampsia is a multisystem disorder that manifests after 20 weeks’ gestation. It is a leading cause of maternal and fetal morbidity and mortality. Approximately 25% of early-onset preeclampsia cases are severe, and 85% of pregnant women with severe preeclampsia develop multiple organ failure. Stillbirth and early neonatal mortality in women with early-onset preeclampsia are 3%-5% higher than those in cases of late-onset preeclampsia. Birth asphyxia is diagnosed in 100% of newborns. Invasive respiratory support is required in 80% of cases. Every fourth newborn has cardiovascular and central nervous system issues.The analyzed literature demonstrated a possibility of pregnancy prolongation in early-onset preeclampsia using different therapeutic apheresis techniques, which can reduce negative consequences for newborns and mothers.
- Open Access
- 7 April 2022
- Published by The Scientific and Practical Society of Emergency Medicine Physicians in Russian Sklifosovsky Journal "Emergency Medical Care"
- Vol. 11 (1) , 12-21
The Possibilities of Thromboelastography in Assessing Safety of Neuraxial Blocks in Gestational Thrombocytopenia (Clinical Study)
Gestational thrombocytopenia (GT) is the most common type of thrombocytopenia during pregnancy. Unlike other types of thrombocytopenia, it is not accompanied by dysfunction of the cellular component of hemostasis. Currently, a quantitative decrease in platelets in GT is a contraindication to neuraxial blockades (NAB), which significantly reduces the quality of care in childbirth.The aim of the study is to determine the possibility of safe use of neuraxial blockades in gestational thrombocytopenia. A retrospective prospective study involved 70 patients who were performed delivery, depending on obstetric indications, either conservatively or surgically. The patients were divided into two groups. The main group (group No. 1) included 35 patients with gestational thrombocytopenia. The comparison group (group No. 2) consisted of 35 patients with a platelet content above 150×109/l. A comparative intergroup analysis of indicators of a general blood test, coagulogram, thromboelastography with a test for functional fibrinogen before childbirth and 2 days after delivery. The change in platelet content and its effect on the coagulation status of patients during pregnancy were retrospectively analyzed. A comparative assessment of the volume of blood loss during childbirth and the early postpartum period and the risk of complications of neuraxial blockade in patients with and without gestational thrombocytopenia was carried out.It was found that during gestational thrombocytopenia in the perinatal period, there is no decrease in coagulation potential, assessed by the results of coagulography and thromboelastography at a platelet level above 49×109/l. The investigated indicators of hemostasis did not have significant intergroup differences during pregnancy and childbirth. In the group of patients with gestational thrombocytopenia, the volume of blood loss during labor and the postpartum period did not differ from the group without thrombocytopenia, regardless of the method of delivery. The median blood loss after vaginal delivery in group 1 was 225 ml, in group 2 – 250 ml, with abdominal delivery – 572 ml and 386 ml – respectively. In this study, no complications of neuraxial blockade were observed in any of the groups.The results obtained suggest that in patients with gestational thrombocytopenia, even with a significant decrease in platelet content, it is possible to perform neuraxial blockades during labor, taking into account the clinical picture and the absence of coagulation disorders confirmed by thromboelastography.
- 7 April 2022
- Published by The Scientific and Practical Society of Emergency Medicine Physicians in Russian Sklifosovsky Journal "Emergency Medical Care"
- Vol. 11 (1) , 12-21
Open AccessThe Possibilities of Thromboelastography in Assessing Safety of Neuraxial Blocks in Gestational Thrombocytopenia (Clinical Study)
Gestational thrombocytopenia (GT) is the most common type of thrombocytopenia during pregnancy. Unlike other types of thrombocytopenia, it is not accompanied by dysfunction of the cellular component of hemostasis. Currently, a quantitative decrease in platelets in GT is a contraindication to neuraxial blockades (NAB), which significantly reduces the quality of care in childbirth.The aim of the study is to determine the possibility of safe use of neuraxial blockades in gestational thrombocytopenia. A retrospective prospective study involved 70 patients who were performed delivery, depending on obstetric indications, either conservatively or surgically. The patients were divided into two groups. The main group (group No. 1) included 35 patients with gestational thrombocytopenia. The comparison group (group No. 2) consisted of 35 patients with a platelet content above 150×109/l. A comparative intergroup analysis of indicators of a general blood test, coagulogram, thromboelastography with a test for functional fibrinogen before childbirth and 2 days after delivery. The change in platelet content and its effect on the coagulation status of patients during pregnancy were retrospectively analyzed. A comparative assessment of the volume of blood loss during childbirth and the early postpartum period and the risk of complications of neuraxial blockade in patients with and without gestational thrombocytopenia was carried out.It was found that during gestational thrombocytopenia in the perinatal period, there is no decrease in coagulation potential, assessed by the results of coagulography and thromboelastography at a platelet level above 49×109/l. The investigated indicators of hemostasis did not have significant intergroup differences during pregnancy and childbirth. In the group of patients with gestational thrombocytopenia, the volume of blood loss during labor and the postpartum period did not differ from the group without thrombocytopenia, regardless of the method of delivery. The median blood loss after vaginal delivery in group 1 was 225 ml, in group 2 – 250 ml, with abdominal delivery – 572 ml and 386 ml – respectively. In this study, no complications of neuraxial blockade were observed in any of the groups.The results obtained suggest that in patients with gestational thrombocytopenia, even with a significant decrease in platelet content, it is possible to perform neuraxial blockades during labor, taking into account the clinical picture and the absence of coagulation disorders confirmed by thromboelastography.
- Open Access
- 19 January 2022
- Published by Practical Medicine Publishing House in Annals of Critical Care
- No. 4
Differential diagnostic capabilities of calculating the level of neutrophil extracellular traps in the venous blood of pregnant women: a comparative prospective study
Introduction. Severe preeclampsia in early stages can be detected by isolated thrombocytopenia, which makes it difficult to diagnose it in time and carry out the necessary therapeutic measures. As a rule, the diagnosis of severe preeclampsia can be declared with a detailed clinical and laboratory researches, and it increases the risks for the mother and the embryo. However, if there are no clinical symptoms of preeclampsia except of thrombocytopenia, there is a problem of differential diagnosis between thrombocytopenia, which has the same symptoms as preeclampsia and gestational thrombocytopenia, which is a physiological peculiarity and does not require any medical interventions and restrictions. Nowadays there are no screening methods for differential diagnosis of these conditions. Objectives. To estimate the possibilities of determing the level of neutrophil extracellular traps (NETs) during the differential diagnosis of preeclampsia and gestational thrombocytopenia. Materials and methods. The comparative analysis of the level of NETs was carried out in three groups of pregnant women. Group 1 included patients with severe preeclampsia (n = 45), group 2-patients with gestational thrombocytopenia (n = 44) and group 3 consisted of healthy pregnant women (n = 44). Results. The research revealed significant increase in the level of NETs in the group of patients with preeclampsia (15.26 %,) compared with the groups of healthy patients (7.65 %, p = 0.001) and patients with gestational thrombocytopenia (7.04 %, р = 0.002). There were no significant differences in the level of NETs between the groups of healthy patients and patients with gestational thrombocytopenia. Conclusions. A significant increase of the level of NETs among the patients with severe preeclampsia allows us to consider the method of calculating the level of NETs among patients with thrombocytopenia which can be detected after the 20th week of pregnancy, if there are no other laboratory and clinical signs of preeclampsia as a screening method for early diagnosis of this complication.
- 19 January 2022
- Published by Practical Medicine Publishing House in Annals of Critical Care
- No. 4
Open AccessDifferential diagnostic capabilities of calculating the level of neutrophil extracellular traps in the venous blood of pregnant women: a comparative prospective study
Introduction. Severe preeclampsia in early stages can be detected by isolated thrombocytopenia, which makes it difficult to diagnose it in time and carry out the necessary therapeutic measures. As a rule, the diagnosis of severe preeclampsia can be declared with a detailed clinical and laboratory researches, and it increases the risks for the mother and the embryo. However, if there are no clinical symptoms of preeclampsia except of thrombocytopenia, there is a problem of differential diagnosis between thrombocytopenia, which has the same symptoms as preeclampsia and gestational thrombocytopenia, which is a physiological peculiarity and does not require any medical interventions and restrictions. Nowadays there are no screening methods for differential diagnosis of these conditions. Objectives. To estimate the possibilities of determing the level of neutrophil extracellular traps (NETs) during the differential diagnosis of preeclampsia and gestational thrombocytopenia. Materials and methods. The comparative analysis of the level of NETs was carried out in three groups of pregnant women. Group 1 included patients with severe preeclampsia (n = 45), group 2-patients with gestational thrombocytopenia (n = 44) and group 3 consisted of healthy pregnant women (n = 44). Results. The research revealed significant increase in the level of NETs in the group of patients with preeclampsia (15.26 %,) compared with the groups of healthy patients (7.65 %, p = 0.001) and patients with gestational thrombocytopenia (7.04 %, р = 0.002). There were no significant differences in the level of NETs between the groups of healthy patients and patients with gestational thrombocytopenia. Conclusions. A significant increase of the level of NETs among the patients with severe preeclampsia allows us to consider the method of calculating the level of NETs among patients with thrombocytopenia which can be detected after the 20th week of pregnancy, if there are no other laboratory and clinical signs of preeclampsia as a screening method for early diagnosis of this complication.